Boeing’s highly anticipated 777X widebody jet is facing another setback, with deliveries now pushed back to early 2027 instead of next year, according to a Bloomberg report citing industry sources. This marks yet another delay for the flagship aircraft program, which was originally expected to enter service in 2020.
Launch customer Deutsche Lufthansa AG is already adjusting its fleet strategy and does not expect the 777X to be operational before 2027. Boeing, meanwhile, declined to comment on the latest delay.
The extended timeline is likely to come with financial consequences. Several Wall Street analysts forecast that Boeing could announce a charge between $1 billion and $4 billion in its upcoming third-quarter earnings report to account for the delay. The company has already absorbed more than $10 billion in charges since the program’s launch in 2013.
Boeing CEO Kelly Ortberg recently admitted that certification efforts remain behind schedule, describing the process as a “mountain of work.” While Ortberg emphasized that no new technical flaws have emerged, the slow pace of regulatory approval continues to hinder progress. The aircraft was last scheduled for delivery in 2026, already six years late.
Investment analysts are now lowering their projections for Boeing’s free cash flow in 2026, anticipating financial strain from the extended delay. RBC Capital Markets aerospace analyst Ken Herbert told investors he expects deliveries to start no earlier than the second half of 2027.
The 777X, designed as Boeing’s most advanced widebody jet with improved fuel efficiency and larger capacity, has been positioned as a critical program for the company’s long-term competitiveness against Airbus. However, repeated delays and mounting costs highlight the challenges Boeing faces in regaining market confidence and meeting airline demand.
With certification hurdles still looming, the 777X’s future timeline remains uncertain, casting another shadow over Boeing’s financial recovery and strategic outlook.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



